Bionano Genomics, Inc. (BNGO)

1.62 -0.04 (-2.41%) USD  |  NASDAQ  |  Dec 12, 16:00
1.62 0.00 (0.00%) After-Hours: 20:00
More

Bionano Genomics Research and Development Expense (Quarterly): 2.844M for Sept. 30, 2025

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for BNGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Bruker Corp. 98.30M
Azenta, Inc. 8.258M
Harvard Bioscience, Inc. 2.132M
Phibro Animal Health Corp. --
Kestra Medical Technologies Ltd. 4.878M